Durham-based Priovant Therapeutics has announced positive results from its Phase 2 BEACON study evaluating brepocitinib in cutaneous sarcoidosis (CS). CS is an inflammatory granulomatous skin disease ...

Durham-based Precision BioSciences, a gene-editing company, has received regulatory clearance to begin a clinical study of its potential treatment for Duchenne muscular dystrophy (DMD), a rare ...

A trusted leader who offered a steady hand and strong leadership on an interim basis in an ever-changing research environment, Sharon Paynter, Ph.D., has been named Senior Vice Provost for Research ...

If 2025 had a theme for the Charlotte region's life sciences ecosystem, it was this: years of planning finally meeting their moment. From landmark facility openings to record-breaking workforce ...

Durham Tech Connects is a career networking event for professionals, students, and alumni from life sciences and related fields. This event is hosted by Durham Tech's Life Sciences Program.

A new Research Triangle company, Persistence Therapeutics, is developing a small, implantable device that generates and delivers genetically engineered T cells directly inside the body.

The GXP site feeds into a surge of biomanufacturing activity in the state’s Eastern Region. The region scored $7.1 billion of ...

The Greater Raleigh Chamber and Wake County Economic Development joined forces to host a dynamic event that explores the evolving life sciences landscape in Wake County and the Research Triangle ...